<DOC>
	<DOC>NCT02212470</DOC>
	<brief_summary>The purpose of this study is to evaluate whether the results of drug eluting balloon are equivalent to the Nitinol stent implantation in the Superficial Femoral Artery.</brief_summary>
	<brief_title>Drug Eluting Ballon Versus Stenting in the Superficial Femoral Artery</brief_title>
	<detailed_description />
	<criteria>Patients over 18 years with critical lower limb ischemia, Ruhtherford 3 or higher, with angiographic documentation of greater than 70% or occlusion in the superficial femoral artery, with a maximum extension of 10 cm stenosis. The popliteal artery and at least one leg artery must be patent. Pregnancy, thrombophilia, coagulation disorders, presence of active or recent bleeding, severe allergy to iodinated contrast, renal or hepatic disease, acute limb ischemia, prior surgical bypass or angioplasty (with or without stent) on the target artery, obstructive disease (stenosis&gt; 50%) of the aortoiliac segment ipsilateral to the target (if the aortoiliac is pretreated, the patient may be included)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>